WETTIG THANE (Chief Commercial Officer) sold 9.3% of their position (2.80K shares) of KYNTRA BIO, INC. on the open market
Open‑market sale worth $19.9K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/18/2026ACC: 0001815638-26-000005
Officer· Chief Commercial Officer
Since Jun 2020
-2.80K
Net shares
Net seller
$19.9K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
2.80K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−2.80K
Price / share
$7.09
Trade value
$19.85K
% of position
9.3%
5/14/2026
30K→27.20K
Total
Net shares
−2.80K
Net value
-$19.85K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/14/2026 | P · Purchase | −2.80K | $7.09 | $19.85K | 9.3% | 30K | 27.20K |
| Total | −2.80K | -$19.85K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned40.00
Total
40.00 indirect40.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 40.00 | Indirect |
| Total | 40.00 | 40.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported